ACC/AHA Heart Failure Stage C Guidelines

Heart Failure Stage C Pocket Guide

ACC AHA Heart Failure Stage C Guidelines Pocket Guide Web App

Issue link: https://eguideline.guidelinecentral.com/i/1227234

Contents of this Issue

Navigation

Page 2 of 5

Drug Table Drug Initial Daily Dose(s) Maximum Daily Doses(s) ACE Inhibitors Captopril 6.25 mg tid 50 mg tid Enalapril 2.5 mg bid 10–20 mg bid Fosinopril 5–10 mg qd 40 mg qd Lisinopril 2.5–5 mg qd 20–40 mg qd Perindopril 2 mg qd 8–16 mg qd Quinapril 5 mg bid 20 mg bid Ramipril 1.25–2.5 mg qd 10 mg qd Trandolapril 1 mg qd 4 mg qd ARBs Candesartan 4–8 mg qd 32 mg qd Losartan 25–50 mg qd 50–150 mg qd Valsartan 20–40 mg bid 160 mg bid ARNI Sacubitril/valsartan 49/51 mg bid (therapy may be initiated at 24/26 mg bid) 97/103 mg bid I f channel inhibitor Ivabradine 5 mg bid 7.5 mg bid Aldosterone Antagonists Spironolactone 12.5–25 mg qd 25 mg qd or bid Eplerenone 25 mg qd 50 mg qd Beta Blockers Bisoprolol 1.25 mg qd 10 mg qd Carvedilol 3.125 mg bid 50 mg bid Carvedilol CR 10 mg qd 80 mg qd Metoprolol succinate extended release (metoprolol CR/XL) 12.5–25 mg qd 200 mg qd Isosorbide dinitrate and hydralazine Fixed-dose combination 20 mg isosorbide dinitrate/37.5 mg hydralazine tid 40 mg isosorbide dinitrate/ 75 mg hydralazine tid Isosorbide dinitrate and hydralazine 20–30 mg isosorbide dinitrate/25–50 mg hydralazine tid or qid 40 mg isosorbide dinitrate tid with 100 mg hydralazine tid Modified (Table 15) from the 2013 HF guideline

Articles in this issue

view archives of ACC/AHA Heart Failure Stage C Guidelines - Heart Failure Stage C Pocket Guide